As per our new research report “ Global Monoclonal Antibody Market Analysis”, Europe is the second largest market for mAbs in the world. Our study indicates that ten major mAb products are commercially available in Europe, including Remicade, Zevalin, Campath, Herceptin, Rituxan, Simulect, Zenapax, Synagis, ReoPro, and the fully human Mab Humira. In fact, physicians are increasingly adopting mAbs because of its superior side effect profile in the European region.
We have identified some critical factors acting as a catalyst for the industry’s current and future growth outlook. The report reveals that the European therapeutic mAbs markets are mainly driven by the sales of the top five drugs, which constitute about 90% of revenue. The success of these drugs has encouraged companies to invest in this market in a quest to leverage long-term growth opportunities. Moreover, continued research will yield innovative products and support growth momentum in the European mAbs market in future.
Besides, our report provides a thorough research and prudent analysis of the global monoclonal antibodies therapeutics market. The systematic and thorough research studies the global monoclonal antibodies therapeutics market to provide an insight into its various segments, including Oncology, Autoimmune & Inflammatory Diseases, Respiratory Diseases, Neurological Diseases, and Cardiovascular Diseases. Further, the comprehensive analysis of the market at a regional level highlights the United States as the current highest share-holder.
" Global Monoclonal Antibody Market Analysis" provides extensive information on the traditional markets as well as on the emerging technologies. Besides, an insight of trends prevailing in the regional monoclonal therapeutics market segments across the globe along with analysis of key drugs has been covered in the report. Analysis and statistics regarding market size, growth, share, segmentation, and geographic distribution have been thoroughly studied in the report to present a comprehensive view of the market. The report has thoroughly examined market drivers, industrial developments, alliances & acquisitions, and competitive landscape to enable clients understand the market structure and its progress in coming years.
For more information visit: http://www.rncos.com/Report/IM279.htm |
